Robotic Compared With Laparoscopic Sacrocolpopexy A Randomized Controlled Trial
Robotic Compared With Laparoscopic Sacrocolpopexy A Randomized Controlled Trial
复制标题
DOI：
10.1097/aog.0000000000000006
复制
发表时间：
2014-01-01
影响因子：
7.2
通讯作者：
Kenton, Kimberly
中科院分区：
文献类型：
--
作者：
Anger, Jennifer T.;Mueller, Elizabeth R.;Kenton, Kimberly
目的：腹腔镜和机器人骶骨阴道固定术广泛用于盆腔器官脱垂（POP）治疗。缺乏比较结果和成本的证据。我们比较了随机分配到腹腔镜骶骨阴道固定术的女性与机器人骶骨阴道固定术相比的成本和临床相关结局。METHODS：有症状的POP II期或更高阶段的参与者，包括显著的心尖支持丧失，被随机分配到腹腔镜或机器人骶骨阴道固定术。我们比较了6周内的手术费用（包括机器人费用、初始住院费用）和再住院费用。次要结局包括术后疼痛、POP量化、症状严重程度和生活质量以及不良事件。结果：我们随机分配了78名女性（平均年龄59岁）：腹腔镜（n=538）和机器人（n=540）。机器人骶骨阴道固定术组的初始住院费用较高（19，616美元与11，573美元，P
OBJECTIVE: Laparoscopic and robotic sacrocolpopexy are widely used for pelvic organ prolapse (POP) treatment. Evidence comparing outcomes and costs is lacking. We compared costs and clinically relevant outcomes in women randomized to laparoscopic sacrocolpopexy compared with robotic sacrocolpopexy.METHODS: Participants with symptomatic stage POP II or greater, including significant apical support loss, were randomized to either laparoscopic or robotic sacrocolpopexy. We compared surgical costs (including costs for robot, initial hospitalization) and rehospitalization within 6 weeks. Secondary outcomes included postoperative pain, POP quantification, symptom severity and quality of life, and adverse events. RESULTS: We randomized 78 women (mean age 59 years): laparoscopic (n=538) and robotic (n=540). The robotic sacrocolpopexy group had higher initial hospital costs ($19,616 compared with $11,573, P